Aveanna Healthcare (AVAH) vs P3 Health Partners (PIII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Aveanna Healthcare (AVAH) has outperformed P3 Health Partners (PIII) over the past year, gaining 39.0% versus a loss of 45.9%. Over five years, AVAH leads with a +82.0% price change compared with -99.0% for PIII. Aveanna Healthcare is the larger company by market cap ($2.67 billion vs $1.01 billion), about 2.7 times the size.
Aveanna Healthcare converts more of its revenue into profit, with a net margin of 9.2% versus -10.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVAH | PIII |
|---|---|---|
| Share price | $12.25 | $4.95 |
| Market cap | $2.67B | $1.01B |
| 1-day change | +0.08% | -6.78% |
| YTD return | +49.94% | +41.83% |
| 1-year return | +39.05% | -45.90% |
| 5-year return | +82.02% | -99.00% |
| P/E ratio (TTM) | 9.72 | — |
| Forward P/E | 13.50 | — |
| EPS (TTM) | $1.26 | $-33.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.43B | $1.46B |
| Revenue growth (YoY) | +20.19% | -2.76% |
| Net income (latest FY) | $225.03M | $-147.95M |
| Gross margin | 33.31% | — |
| Operating margin | 10.54% | -18.53% |
| Net margin | 9.25% | -10.14% |
| 52-week high | $14.71 | $16.89 |
| 52-week low | $5.93 | $1.52 |
| Distance from 52-week high | -16.72% | -70.69% |
| Analyst consensus | buy | none |
| Avg. price target upside | +21.22% | +263.64% |
| Average volume | 3.06M | 32.38K |
| Shares outstanding | 218.29M | 3.91M |
| Employees | 3,500 | 320 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Aveanna Healthcare is about 2.7 times larger than P3 Health Partners by market value ($2.67B vs $1.01B).
- AVAH has outperformed PIII by 84.9 percentage points over the past year.
- Aveanna Healthcare is more profitable, keeping 9.2 cents of every revenue dollar as net income versus -10.1 cents for P3 Health Partners.
- Aveanna Healthcare grew revenue faster in its latest fiscal year (+20.19% vs -2.76%).
About Aveanna Healthcare
AVAH stock →Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Health Care · Medical/Nursing Services · 3,500 employees
About P3 Health Partners
PIII stock →P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers.
Health Care · Medical/Nursing Services · 320 employees
AVAH vs PIII FAQ
Which is bigger, Aveanna Healthcare or P3 Health Partners?
Aveanna Healthcare (AVAH) is larger, with a market capitalization of $2.67B compared with $1.01B for P3 Health Partners (PIII).
Which stock has performed better over the past year, AVAH or PIII?
AVAH returned +39.05% over the past 12 months, compared with -45.90% for PIII (price return, excluding dividends). Past performance does not predict future results.
Are Aveanna Healthcare and P3 Health Partners in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.